Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer.
Haonan LuPaula CunneaKatherine NixonNatasha RinneEric O AboagyeChristina FotopoulouPublished in: British journal of cancer (2021)
ALG5 has been identified as an independent prognostic biomarker for poor prognosis in advanced HGSOC patients despite CGR. This sets a promising platform for biomarker combinations and further validations towards future personalised surgical care.
Keyphrases
- high grade
- poor prognosis
- long non coding rna
- end stage renal disease
- low grade
- newly diagnosed
- healthcare
- chronic kidney disease
- ejection fraction
- high throughput
- palliative care
- small molecule
- prognostic factors
- current status
- peritoneal dialysis
- patient reported outcomes
- quality improvement
- chronic pain
- health insurance
- single cell